NDC Code | 43742-1507-1 |
Package Description | 30 mL in 1 BOTTLE, DROPPER (43742-1507-1) |
Product NDC | 43742-1507 |
Product Type Name | HUMAN OTC DRUG |
Proprietary Name | Female Stimulant |
Non-Proprietary Name | Lilium Tigrinum, Bovista, Cypripedium Pubescens, Hydrastis Canadensis, Petroselinum Sativum, Aquilegia Vulgaris, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Heart (suis), Kreosotum, Oophorinum (suis), Uterus (suis), Folliculinum, Lachesis Mutus, Magnesia Phosphorica, Mercurius Solubilis, Sepia, Pineal Gland (suis), Hypophysis Suis, Aconiticum Acidum Cis-, Apis Venenum Purum, Estradiol, Progesterone, Testosterone, Placenta Totalis Suis, Faecalis (alkaligenes), Mutabile Bacillus (bach) |
Dosage Form | LIQUID |
Usage | ORAL |
Start Marketing Date | 20190820 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Manufacturer | Deseret Biologicals, Inc. |
Substance Name | ACONITIC ACID, (Z)-; ALCALIGENES FAECALIS; APIS MELLIFERA VENOM; AQUILEGIA VULGARIS; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; ESCHERICHIA COLI; ESTRADIOL; ESTRONE; GOLDENSEAL; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPERDON UTRIFORME FRUITING BODY; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MERCURIUS SOLUBILIS; PETROSELINUM CRISPUM WHOLE; PORK HEART; PROGESTERONE; SEPIA OFFICINALIS JUICE; SUS SCROFA ADRENAL GLAND; SUS SCROFA OVARY; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; SUS SCROFA UTERUS; TESTOSTERONE; WOOD CREOSOTE |
Strength | 10; 30; 18; 8; 6; 30; 30; 8; 6; 10; 4; 6; 10; 12; 6; 8; 30; 13; 8; 8; 16; 10; 6; 8; 8; 30; 8 |
Strength Unit | [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
Pharmacy Classes | Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Calculi Dissolution Agent [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Progesterone [CS], Progesterone [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
DEA Schedule | CIII |